1. Home
  2. SLGN vs EWTX Comparison

SLGN vs EWTX Comparison

Compare SLGN & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silgan Holdings Inc.

SLGN

Silgan Holdings Inc.

N/A

Current Price

$39.68

Market Cap

4.3B

Sector

Industrials

ML Signal

N/A

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

N/A

Current Price

$40.02

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLGN
EWTX
Founded
1987
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.3B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
SLGN
EWTX
Price
$39.68
$40.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
13
Target Price
$51.45
★ $56.17
AVG Volume (30 Days)
824.0K
★ 1.4M
Earning Date
10-29-2026
11-04-2026
Dividend Yield
★ 2.11%
N/A
EPS Growth
★ 4.65
N/A
EPS
2.30
★ 8.86
Revenue
★ $4,489,927,000.00
N/A
Revenue This Year
$4.16
N/A
Revenue Next Year
$1.86
N/A
P/E Ratio
$17.33
★ $4.65
Revenue Growth
★ 0.92
N/A
52 Week Low
$33.70
$19.76
52 Week High
$49.41
$48.78

Technical Indicators

Market Signals
Indicator
SLGN
EWTX
Relative Strength Index (RSI) 47.49 44.25
Support Level $36.83 $37.22
Resistance Level $41.87 $41.60
Average True Range (ATR) 1.18 3.20
MACD -0.30 -0.37
Stochastic Oscillator 10.78 26.45

Price Performance

Historical Comparison
SLGN
EWTX

About SLGN Silgan Holdings Inc.

Silgan Holdings Inc is a manufacturer of sustainable rigid packaging solutions for the world's essential consumer goods products. Its products include: dispensing and specialty closures for fragrance and beauty, food, beverage, personal and health care, home care and lawn and garden products; steel and aluminum containers for pet and human food and general line products; and custom designed plastic containers for pet and human food, consumer health and pharmaceutical, personal care, home care, lawn and garden and automotive products.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: